(Q39367299)

English

Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

D Armstrong

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

S J O Veldhuyzen van Zanten

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

A N Barkun

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

N Chiba

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

A B R Thomson

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

S Smyth

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

P Sinclair

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

B Chakraborty

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

R J White

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

CADET-HR Study Group

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1189-1202

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid‐related dyspepsia in general practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Heartburn treatment in primary care: randomised, double blind study for 8 weeks

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Symptomatic gastroesophageal reflux: incidence and precipitating factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta‐analysis of long‐term omeprazole trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Short-term treatment of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02466.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2005.02466.X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39367299&oldid=1823101835"